Financial results - IMUNOPLANT SRL

Financial Summary - Imunoplant Srl
Unique identification code: 17554817
Registration number: J05/1029/2005
Nace: 1729
Sales - Ron
-
Net Profit - Ron
-17.827
Employees
Open Account
Company Imunoplant Srl with Fiscal Code 17554817 recorded a turnover of 2024 of - , with a net profit of -17.827 and having an average number of employees of - . The company operates in the field of Fabricarea altor articole din hartie si carton n.c.a. having the NACE code 1729.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Imunoplant Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 7.969 21.372 31.379 39.268 49.442 16.218 17.445 23.882 11.889 0
Total Income - EUR 7.971 21.386 31.392 39.269 49.443 16.218 17.445 25.198 12.618 3.023
Total Expenses - EUR 7.615 19.612 30.310 22.249 39.158 31.434 22.388 19.974 9.558 20.777
Gross Profit/Loss - EUR 356 1.774 1.083 17.020 10.285 -15.215 -4.943 5.224 3.059 -17.754
Net Profit/Loss - EUR 117 1.132 141 15.949 9.054 -15.700 -5.466 4.522 2.585 -17.827
Employees 1 1 0 0 0 0 0 0 0 0
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Imunoplant Srl

Rating financiar

Financial Rating -
IMUNOPLANT SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Imunoplant Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Imunoplant Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Imunoplant Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Imunoplant Srl - CUI 17554817

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 180 16.412 21.950 38.719 29.029 15.713 6.746 631 0 0
Current Assets 8.604 14.022 13.756 25.867 38.079 39.185 42.824 36.326 38.479 15.598
Inventories 1.378 3.861 529 803 1.042 0 0 0 0 0
Receivables 5.641 9.990 13.404 24.019 34.545 37.987 42.319 35.775 38.302 15.539
Cash 1.584 171 -176 1.044 2.492 1.198 505 552 177 59
Shareholders Funds 6.935 7.996 8.002 23.804 32.398 16.100 10.277 14.830 17.406 -518
Social Capital 67 67 66 64 63 79 77 77 77 76
Debts 9.428 22.438 27.705 40.781 35.150 39.229 39.714 22.127 21.483 16.116
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "1729 - 1729"
CAEN Financial Year 8710
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 15.598 euro in 2024 which includes Inventories of 0 euro, Receivables of 15.539 euro and cash availability of 59 euro.
The company's Equity was valued at -518 euro, while total Liabilities amounted to 16.116 euro. Equity decreased by -17.827 euro, from 17.406 euro in 2023, to -518 in 2024.

Risk Reports Prices

Reviews - Imunoplant Srl

Comments - Imunoplant Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.